18 results match your criteria: "The Icahn School of Medicine at Mt Sinai[Affiliation]"

Hysterectomy for Large Uterus by Minimally Invasive Surgery (MIS).

JSLS

October 2024

Department of OB/GYN, BronxCare Health System, Bronx, New York. (Drs. Wang, Uzianbaeva, Hughes, and Mehdizadeh).

Background And Objective: When the uterus is or more than 18 to 20 weeks in size, laparotomy but not minimally invasive surgery (MIS) is commonly performed for hysterectomy. It is, however, acknowledged that MIS carries numerous benefits to patients compared to laparotomy. The uterine size should therefore not be an excluding factor for MIS.

View Article and Find Full Text PDF

Introduction: Patients with psoriasis (PSO) and psoriatic arthritis (PsA) may frequently switch biologic therapies over the course of treatment because of symptom variability and individual responses. Real-world studies analyzing patient characteristics and clinical factors associated with biologic switching are limited.

Methods: This longitudinal cohort study used real-world data from the CorEvitas Psoriasis Registry to evaluate the relationship between associated disease factors and biologic switching among patients with PSO and PsA in the United States (US) and Canada following initiation of a biologic.

View Article and Find Full Text PDF
Article Synopsis
  • Bimekizumab is a monoclonal antibody that selectively targets interleukin-17F and IL-17A, and this study assessed its efficacy and safety compared to a placebo in patients with active psoriatic arthritis who had not responded to TNFα inhibitors.
  • The BE COMPLETE trial was a phase 3 study involving 400 patients from 11 countries, where participants were randomized to receive either bimekizumab or placebo and monitored for 16 weeks.
  • Results showed significant improvement in 43% of patients receiving bimekizumab based on the American College of Rheumatology criteria, indicating its potential as an effective treatment for this condition.
View Article and Find Full Text PDF
Article Synopsis
  • Bimekizumab is an experimental monoclonal antibody targeting IL-17A and IL-17F, being tested for its effectiveness in treating active psoriatic arthritis in patients who haven't previously used biologic DMARDs.
  • The BE OPTIMAL trial involved 852 participants and compared bimekizumab, placebo, and adalimumab over 52 weeks, assessing the primary outcome of achieving a 50% improvement in ACR criteria at week 16.
  • Results showed that 44% of patients on bimekizumab reached this improvement compared to the other groups, indicating its potential efficacy in treating the condition.*
View Article and Find Full Text PDF

Four recent reports from the National Academies of Sciences, Engineering, and Medicine framed around the issues of poverty; mental, emotional, and behavioral health; adolescence; and young family health and education build on extensive recent evidence of what can be done to improve the health and well-being of children, youth, and families. We describe the process of generating the reports, briefly summarize each report's content, and identify crosscutting themes and recommendations. We also note how the coronavirus disease 2019 (COVID-19) pandemic highlights major disparities and systemic problems addressed in the reports and heightens the relevance of their policy recommendations.

View Article and Find Full Text PDF
Article Synopsis
  • Disruption of brain insulin signaling is linked to a higher risk of Alzheimer's disease (AD) in patients with type 2 diabetes (T2D), suggesting a potential connection between insulin management and AD risk.
  • A study explored the effects of intranasal treatments with insulin, exenatide (a GLP-1 agonist), and a combination of both on learning and brain health in both normal and AD-like mice.
  • The combination therapy showed promising results by reducing certain gene expressions related to insulin signaling and improving learning in AD-like mice, although changes in amyloid beta levels were not statistically significant.
View Article and Find Full Text PDF

Sarcoidosis of the external nose: the role of pharmacologic rhinoplasty in diagnosis and treatment.

Sarcoidosis Vasc Diffuse Lung Dis

April 2018

Department of Otolaryngology-Head and Neck Surgery, The Icahn School of Medicine at Mt Sinai, New York, New York, USA.

Subcutaneous sarcoidosis is a rare manifestation of a systemic disease. Sarcoidosis most often affects the pulmonary system but can also affect sinonasal tissues including the cutaneous and subcutaneous layers. It can be suspected in patients who may or may not have a prior diagnosis of sarcoidosis but who develop nodules or lesions over the nasal dorsum after trauma or rhinoplasty.

View Article and Find Full Text PDF

T-helper 1 and T-helper 17 lymphocytes mediate acute graft--host disease (GvHD). Interleukin 12 is critical for T-helper 1 differentiation and interleukin 23 for T-helper 17 maintenance. Interleukin 12 and 23 are heterodimeric cytokines that share the p40 subunit (IL-12/IL-23p40).

View Article and Find Full Text PDF

Objectives: Long-term voice outcome (LTVO) after radiation (XRT) or trans-oral laser microsurgery (TLM) is unclear. This study is a multi-modality analysis of LTVO following XRT or TLM in patients with early glottic cancer. We hypothesize that as compared with TLM, LTVO is worse in the XRT group because of progressive fibrosis in the glottic tissue MATERIAL AND METHODS: One hundred and two patients with early glottic carcinoma (carcinoma in situ, T1, T2) were included.

View Article and Find Full Text PDF

Myostatin is small glycopeptide that is produced and secreted by skeletal muscle. It is a potent negative regulator of muscle growth that has been associated with conditions of frailty. In C2C12 cells, myostatin limits cell differentiation.

View Article and Find Full Text PDF

Natural killer (NK) cells are innate immune cells that become progressively exhausted in advanced stage cancer, crippling their ability to execute antitumor functions. We previously characterized the nature of NK cell exhaustion in metastatic melanoma patients, reporting a correlation with high expression of TIM-3. Blockade of this immune checkpoint molecule reversed the exhausted phenotype and improved NK cell function.

View Article and Find Full Text PDF

Elevated serum advanced glycation endproducts in obese indicate risk for the metabolic syndrome: a link between healthy and unhealthy obesity?

J Clin Endocrinol Metab

May 2015

Department of Geriatrics, Division of Experimental Diabetes (W.C., E.T., L.G., R.P., K.Y., L.T., X.C., H.V.), Department of Medicine, Division of Nephrology (J.U., H.V.), and Translational and Molecular Imaging Institute (V.M., Z.A.F.), The Icahn School of Medicine at Mt Sinai, New York, New York 10029; and George Institute for Global Health (M.W.), University of Oxford, Oxford OX1 3QX, United Kingdom, and University of Sydney, Sydney 2006, Australia.

Context: Although obesity can predispose to the metabolic syndrome (MS), diabetes, and cardiovascular disease, not all obese subjects develop MS, hence the need for new indicators of risk for this syndrome. Advanced glycation end products (AGEs) correlate with factors involved in the MS, including inflammation and insulin resistance (IR). Because AGEs can be derived from food and are modifiable, it is important to determine whether they are a risk factor for MS.

View Article and Find Full Text PDF

Objectives: Community viral load (CVL) estimates vary based on analytic methods. We extended the CVL concept and used data from the Veterans Health Administration (VA) to determine trends in the health care system viral load (HSVL) and its sensitivity to varying definitions of the clinical population and assumptions regarding missing data.

Methods: We included HIV-infected patients in the Veterans Aging Cohort Study, 2000-2010, with at least one documented CD4 count, HIV-1 RNA or antiretroviral prescription (n = 37 318).

View Article and Find Full Text PDF

Study Objective: Calcium channel blocker poisonings account for a substantial number of reported deaths from cardiovascular drugs. Although supportive care is the mainstay of treatment, experimental therapies such as high-dose insulin-euglycemia and lipid emulsion have been studied in animal models and used in humans. In the most severe cases, even aggressive care is inadequate and deaths occur.

View Article and Find Full Text PDF

It has recently been appreciated that atherosclerosis is predominantly an inflammatory process. Atherosclerosis begins with a fatty streak, which is made up almost entirely of monocyte-derived macrophages. The development of an atheroma continues as T-cells, mast cells, and other inflammatory cells are recruited to the intima.

View Article and Find Full Text PDF